Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Are probiotics detectable in human feces after oral uptake by healthy volunteers? ✅
Wiener klinische Wochenschrift (Wien Klin Wochenschr ) Vol: 119 Issue 15-16 Pages: 456-62 Pub: 2007 Epub: Authors Prilassnig M , Wenisch C , Daxboeck F , Feierl G , |
|
|
Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection. ✅
Go to Publication ✅
Infection and immunity (Infect Immun ) Vol: 82 Issue 5 Pages: 1801-12 Pub: 2014 May Epub: 2014 Feb 18 Authors Kleta S , Nordhoff M , Tedin K , Wieler LH , Kolenda R , Oswald S , Oelschlaeger TA , Bleiss W , Schierack P , |
|
|
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. ✅
Go to Publication ✅
Mucosal immunology (Mucosal Immunol ) Vol: 2 Issue 2 Pages: 166-72 Pub: 2009 Mar Epub: 2008 Nov 26 Authors Möndel M , Schroeder BO , Zimmermann K , Huber H , Nuding S , Beisner J , Fellermann K , Stange EF , Wehkamp J , |
|
|
Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment. ✅
Go to Publication ✅
World journal of hepatology (World J Hepatol ) Vol: 14 Issue 3 Pages: 634-646 Pub: 2022 Mar 27 Epub: Authors Manzhalii E , Moyseyenko V , Kondratiuk V , Molochek N , Falalyeyeva T , Kobyliak N , |
|
|
Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment. ✅
Go to Publication ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 132 Issue 6 Pages: 4020-4032 Pub: 2022 Jun Epub: 2022 Apr 5 Authors Hare PJ , Englander HE , Mok WWK , |
|
|
Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue 14 Pages: Pub: 2023 Jul 20 Epub: 2023 Jul 20 Authors Ma Y , Fu W , Hong B , Wang X , Jiang S , Wang J , |
|
|
Oleanolic Acid Promotes the Formation of Probiotic Escherichia coli Nissle 1917 (EcN) Biofilm by Inhibiting Bacterial Motility. ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 6 Pages: Pub: 2024 May 29 Epub: 2024 May 29 Authors Liu D , Liu J , Ran L , Yang Z , He Y , Yang H , Yu Y , Fu L , Zhu M , Chen H , |
|
|
Enhancing the antibacterial function of probiotic Escherichia coli Nissle: when less is more. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 89 Issue 11 Pages: e0097523 Pub: 2023 Nov 29 Epub: 2023 Nov 6 Authors Bartram E , Asai M , Gabant P , Wigneshweraraj S , |
|
|
Effects of sub-lethal concentrations of thyme and oregano essential oils, carvacrol, thymol, citral and trans-2-hexenal on membrane fatty acid composition and volatile molecule profile of Listeria monocytogenes, Escherichia coli and Salmonella enteritidis. ✅
Go to Publication ✅
Food chemistry (Food Chem ) Vol: 182 Issue Pages: 185-92 Pub: 2015 Sep 1 Epub: 2015 Mar 5 Authors Siroli L , Patrignani F , Gardini F , Lanciotti R , |
|
|
Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 24 Issue 1 Pages: 96 Pub: 2024 Mar 23 Epub: 2024 Mar 23 Authors Dai J , Jiang M , Wang X , Lang T , Wan L , Wang J , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
